Fabrication Chitosan-valine Interpenetrating Polymer Network for Estimation Human Lipid Profile and Total Proteins
DOI:
https://doi.org/10.61841/4ms3pq94Keywords:
Adsorption, Adsorbent, Chitosan, Valine, Ethylene Glycol Diglycidyl Ether, Lipid Profile, Total Protein.Abstract
Present research aimed to determine the efficiency of chitosan-valine bead modification by ethylene glycol diglycidylether (EGDE) as a cross-linker polymer to adsorb lipid profile and total proteins (total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL-C), and total protein (TP)) from human serum in patients suffering from hyperlipidemia in different contact times and temperatures. A UV-Vis spectrophotometer was used to determine the concentration of the adsorption before and after adsorption. The modified beads utilized in this research were portrayed by scanning electron microscopy (SEM) to depict the surface of the beads and by infrared (IR) spectroscopy to affirm the cross-linking reaction. The results showed that the adsorption process attains equilibrium within 3 hours and the extent of adsorbate increased with increasing contact time, temperatures, and concentration. The adsorption isotherms are described by means of the Langmuir and Freundlich isotherms. In the in vitro study, it was found that there were significant decreases (p ≤ 0.05) in the levels of serum “TC, TG, LDL-C, and TP,” while the level of HDL showed a non-significant decrease (p ≥ 0.05) after the adsorption process. It was found that the Langmuir and Freundlich equations both fit. Theadsorption kinetics of the adsorbate was best described by the pseudo first-order reaction model. Free energy of adsorption (∆G ), enthalpy (∆H ), and entropy (∆S ) changes were calculated to predict the nature of adsorption.
Downloads
References
[1] Younes, I., & Rinaudo, M. (2015). Chitin and chitosan preparation from marine sources. Structure,
properties and applications. Marine drugs, 13(3), 1133-1174.
[2] Croisier, F., & Jérôme, C. (2013). Chitosan-based biomaterials for tissue engineering. European Polymer
Journal, 49(4), 780-792.
[3] Anitha, A., Sowmya, S., Kumar, P. S., Deepthi, S., Chennazhi, K. P., Ehrlich, H., ... & Jayakumar, R. (2014).
Chitin and chitosan in selected biomedical applications. Progress in Polymer Science, 39(9), 1644-1667.
[4] Goy, R. C., Britto, D. D., & Assis, O. B. (2009). A review of the antimicrobial activity of chitosan.
Polímeros, 19(3), 241-247.
[5] Venkatesan, J., & Kim, S. K. (2010). Chitosan composites for bone tissue engineering—an overview.
Marine Drugs, 8(8), 2252-2266.
[6] Yi, H., Wu, L. Q., Bentley, W. E., Ghodssi, R., Rubloff, G. W., Culver, J. N., & Payne, G. F. (2005).
Biofabrication with chitosan. Biomacromolecules, 6(6), 2881-2894.
[7] Dev, A., Binulal, N. S., Anitha, A., Nair, S. V., Furuike, T., Tamura, H., & Jayakumar, R. (2010).
Preparation of poly (lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications.
Carbohydrate Polymers, 80(3), 833-838.
[8] Liu, X., & Zhang, L. (2015). Removal of phosphate anions using the modified chitosan beads: adsorption
kinetic, isotherm, and mechanism studies. Powder Technology, 277, 112-119.
[9] Jayakumar, R., Prabaharan, M., Nair, S. V., & Tamura, H. (2010). Novel chitin and chitosan nanofibers in
biomedical applications. Biotechnology advances, 28(1), 142-150.
[10] Prabaharan, M., & Mano, J. F. (2004). Chitosan-based particles as controlled drug delivery systems. Drug
delivery, 12(1), 41-57.
[11] Mahanta, A. K., & Maiti, P. (2016). Chitin and chitosan nanocomposites for tissue engineering. In Chitin
and Chitosan for Regenerative Medicine (pp. 123-149). Springer, New Delhi.
[12] Anitha, A., Deepagan, V. G., Rani, V. D., Menon, D., Nair, S. V., & Jayakumar, R. (2011). Preparation,
characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan
nanoparticles. Carbohydrate Polymers, 84(3), 1158-1164.
[13] Yadollahi, M., Farhoudian, S., & Namazi, H. (2015). One-pot synthesis of antibacterial chitosan/silver bionanocomposite hydrogel beads as drug delivery systems. International journal of biological
Macromolecules, 79, 37-43.
[14] Chaochai, T., Miyaji, H., Yoshida, T., Nishida, E., Furuike, T., & Tamura, H. (2016). Preparation of
Chitosan-Gelatin Based Sponge Cross-Linked with GlcNAc for Bone Tissue Engineering. Journal of
Chitin and Chitosan Science, 4(1), 1-8.
[15] Kyzas, G. Z., & Bikiaris, D. N. (2015). Recent modifications of chitosan for adsorption applications: a
critical and systematic review. Marine drugs, 13(1), 312-337.
[16] Stein, E. A., Honarpour, N., Wasserman, S. M., Xu, F., Scott, R., & Raal, F. J. (2013). Effect of the PCSK9
monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia. Circulation,
CIRCULATIONAHA-113.
[17] N v E. P. Koło z j z k M. S lz V. G l P. A. T n U. L n Y. ... & Kubica, J. (2015).
Effects of subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a
systematic review and meta-analysis. Annals of internal medicine, 163(1), 40-51.
[18] Robinson, J. G., Nedergaard, B. S., Rogers, W. J., Fialkow, J., Neutel, J. M., Ramstad, D., ... & Wasserman,
S. M. (2014). Effect of evolocumab or ezetimibe added to moderate or high-intensity statin therapy on
LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial. Jama,
311(18), 1870-1883.
[19] Wang, W., Huang, X. J., Cao, J. D., Lan, P., & Wu, W. (2014). Immobilization of sodium alginate sulfates on polysulfone ultrafiltration membranes for selective adsorption of low-density lipoprotein. Actabiomaterialia, 10(1), 234-243.
[20] Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Merz, C. N. B., Blum, C. B., Eckel, R. H., ... & McBride, P. (2014). 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 63(25 Part B), 2889-
2934.
[21] Hirayama, A., Honarpour, N., Yoshida, M., Yamashita, S., Huang, F., Wasserman, S. M., & Teramoto, T.
(2014). Effects of evolocumab (AMG 145), a monoclonal antibody to PCSK9, in hypercholesterolemic,
statin-treated Japanese patients at high cardiovascular risk. Circulation Journal, 78(5), 1073-1082.
[22] Gagné C, Gaudet D, Bruckert E, for the Ezetimibe Study Group. Efficacy and safety
coadministered with atorvastatin or simvastatin in patients with homozygous
Familial hypercholesterolemia. Circulation. 2002; 105: 2469-2475.
[23] Rader, D. J., & Kastelein, J. J. (2014). Lomitapide and mipomersen: two first-in-class drugs for reducing
low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia.
Circulation, 129(9), 1022-1032.
[24] Thomas, G. S., Cromwell, W. C., Ali, S., Chin, W., Flaim, J. D., & Davidson, M. (2013). Mipomersen, an
apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe
Hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Journal of the American College of Cardiology, 62(23), 2178-2184.
[25] Wang, W., Huang, X. J., Cao, J. D., Lan, P., & Wu, W. (2014). Immobilization of sodium alginate sulfates
on polysulfone ultrafiltration membranes for selective adsorption of low-density lipoprotein.
Actabiomaterialia, 10(1), 234-243.
[26] Kolovou, G., Hatzigeorgiou, G., Mihas, C., Gontoras, N., Litras, P., Devekousos, D., ... & Mavrogeni, S.
(2012). Changes in lipids and lipoproteins after selective LDL apheresis (7-year experience). Cholesterol,
(2012).
[27] Guoqi Fu, Haofeng Yu, Zhi Yuan, Bin Liu, Bin Shen, and Binglin He, "Chitosan Adsorbents Carrying
Amino Acids for Selective Removal of Low Density Lipoprotein," ARTIFICIAL CELLS, BLOOD
SUBSTITUTES, AND BIOTECHNOLOGY, Vol. 32, No. 2, pp. 303–313, (2004).
[28] Baccar, R., Blánquez, P., Bouzid, J., Feki, M., Attiya, H., & Sarrà, M. (2013). Modeling of adsorption
isotherms and kinetics of a tannery dye onto an activated carbon prepared from an agricultural by-product.
Fuel processing technology, 106, 408-415.
[29] F. Otto, Y. Yang, H. Bei, E.P. George, "Relative effects of enthalpy and entropy on the phase stability of
Equiatomic high-entropy alloys," 11 January (2013), Elsevier.
[30] K.L. K.L.Kapoor, ''A Text Book of Physical Chemistry,'' Macmillan India Limited, India, pp. 449-481 (1994).
[31] Kılı M. Kı ı ık C. Ç p l oğ ll Ö. &Pü ün A. E. 2013 . A o p on o v m l on om
aqueous solutions by bio-char, a by-product of pyrolysis. Applied Surface Science, 283, 856-862.
[32] FU Guoqi, SHI Keyu, YUAN Zhi, HE Binglin, LIU Bin, SHEN Bin & WANG Qishun, Preparation of
tryptophan modified chitosan beads and their adsorption of low density lipoprotein," Chinese Science
Bulletin (2003), Vol. 48, No. 21, 2303-2307.
[33] Yokoyama, S. (1988). Treatment of hypercholesterolemia by chemical adsorption of lipoproteins. Journal
of clinical apheresis, 4(2-3), 66-71.
[34] B k ı U. S. B N. Oz O. Co k n T. Ak l E. K l k T. & B kk loǧl A. 2005 . D
adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience
in two hypercholesterolemic children. Therapeutic Apheresis and Dialysis, 9(6), 469-472.
[35] Dotto, G. L., Moura, J. M. D., Cadaval, T. R. S., & Pinto, L. A. D. A. (2013). Application of chitosan films
for the removal of food dyes from aqueous solutions by adsorption. Chemical Engineering Journal, 214, 8-
16
[36] Maffre, P., Brandholt, S., Nienhaus, K., Shang, L., Parak, W. J., & Nienhaus, G. U. (2014). Effects of
surface functionalization on the adsorption of human serum albumin onto nanoparticles—a fluorescence
correlation spectroscopy study. Beilstein journal of nanotechnology, 5, 2036.
[37] Ghaedi, M., Nasab, A. G., Khodadoust, S., Rajabi, M., & Azizian, S. (2014). Application of activated carbon as adsorbents for efficient removal of methylene blue: Kinetics and equilibrium study. Journal of Industrial and Engineering Chemistry, 20(4), 2317-2324.
[38] Huang, Y., & Keller, A. A. (2015). EDTA-functionalized magnetic nanoparticle sorbents for cadmium and lead-contaminated water treatment. Water research, 80, 159-168.
[39] Turki, A., Guillard, C., Dappozze, F., Ksibi, Z., Berhault, G., & Kochkar, H. (2015). Phenol photocatalytic degradation over anisotropic TiO2 nanomaterials: Kinetic study, adsorption isotherms, and formal mechanisms. Applied Catalysis B: Environmental, 163, 404-414.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
